Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01885897
Title IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

chronic myeloid leukemia

myeloid neoplasm

acute myeloid leukemia

chronic lymphocytic leukemia

acute lymphoblastic leukemia

lymphoma

Therapies

ALT-803

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Masonic Cancer Center, University of Minnesota Minneapolis Minnesota 55455 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field